All In Biotech

Free tool

FAERS Monitor: Cayston

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050814 or its brand name (Cayston, Aztreonam). Reports on generic versions are filed under their own applications.

Reports

6,555

Serious

4,815

73% of reports

Hospitalization

3,276

Death reported

854

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • infective pulmonary exacerbation of cystic fibrosis851
  • dyspnoea432
  • hospitalisation394
  • off label use365
  • cough353
  • cystic fibrosis287
  • pneumonia279
  • death277
  • pyrexia257
  • infection249
  • condition aggravated205
  • haemoptysis187
  • drug ineffective175
  • headache175
  • nausea165

Reports by year received

View as table
YearReports
200422
200525
200634
200720
200820
200927
201048
201168
2012122
2013327
2014340
2015294
2016360
2017384
2018617
20191,172
2020968
2021413
2022281
2023295
2024303
2025219
2026196

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,604 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal851594.4554.8425,001
cystic fibrosisSignal287175.4156.147,027
haemoptysisSignal18721.718.83,644
hospitalisationSignal3948.27.52,514
infectionSignal2495.54.9924
coughSignal3534.03.7815
pneumoniaSignal2792.82.5318
dyspnoeaSignal4322.42.2379
pyrexiaSignal2572.42.1208
condition aggravatedSignal2052.21.9129
off label use3651.31.232
death2771.00.90
headache1750.90.82
nausea1650.70.628
drug ineffective1750.40.4144

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.